An enzyme-linked immunosorbent assay has been developed to detect antibodies to epizootic hemorrhagic disease of deer virus (EHDV). The assay incorporates a monoclonal antibody to EHDV serotype 2 (EHDV-2) that demonstrates specificity for the viral structural protein, VP7. The assay was evaluated with sequential sera collected from cattle experimentally infected with EHDV serotype 1 (EHDV-1) and EHDV-2, as well as the four serotypes of bluetongue virus (BTV), BTV-10, BTV-11, BTV-13, and BTV-17, that currently circulate in the US. A competitive and a blocking format as well as the use of antigen produced from both EHDV-1-and EHDV-2-infected cells were evaluated. The assay was able to detect specific antibody as early as 7 days after infection and could differentiate animals experimentally infected with EHDV from those experimentally infected with BTV. The diagnostic potential of this assay was demonstrated with field-collected serum samples from cattle, deer, and buffalo.
was determined by immune precipitation of [ 35 35]-methionine-labeled viral proteins, polyacrylamide gel electrophoresis, and autoradiography. 9 Positive cultures were amplified, cloned, and retested in the indirect binding assay. Stocks of monoclonal antibody were produced by amplification of hybridoma cultures in roller bottles and collection of supernatant fluid. A monoclonal antibody, designated 4F4.H1, demonstrating an IgG 1 isotype a was selected for development of antibody detection ELISA procedures because it reacted with VP7 of both EHDV-1 and EHDV-2 but did not react appreciably with VP7 of the US serotypes of BTV as demonstrated by immune precipitation (Fig. 1 ). Experimentally infected cattle develop antibodies to the majority of EHDV proteins; in particular, they develop a good antibody response to VP7 by 14 days after infection (DAI) (data not shown). This protein is highly conserved among the serotypes of BTV and is the basis of most ELISA procedures for the detection of antibody to these viruses. 10 This protein is also highly conserved between the two US EHDV serotypes as determined by sequence analysis and the production of cross-reactive antibodies after infection with either serotype (data not shown).
The monoclonal antibody was incorporated into a competitive ELISA (c-ELISA). Virus was purified from BHK-21 cells infected with EHDV-1 (New Jersey) or EHDV-2 (Alberta) 9 and used to coat 96-well microtiter plates b in 0.1 M carbonate buffer, pH 9.6, overnight at 4 C. Unreacted sites were blocked with 1.0% bovine serum albumin (BSA) in 0.1 M carbonate buffer, pH 9.6, for 2 hours at 37 C. The wells were washed with phosphate-buffered saline (PBS) containing 0.05% Tween 20 and 0.1% BSA (washing buffer). In a separate 96-well microtiter plate, monoclonal antibody and test serum samples were mixed in PBS containing 0.1% BSA (diluting buffer) to a final volume of 100 l. The monoclonal antibody/test serum samples were immediately transferred to the antigen-coated wells and incubated for 2 hours at room † ELISA values are presented as percentage of inhibition. ‡ Serum samples were also evaluated by AGID and/or immune precipitation, and the results are expressed as positive (ϩ) or negative (Ϫ). § This serum sample gave a weak positive by AGID and immune precipitation.
temperature. The wells were washed with washing buffer, after which 100 l of biotinylated goat anti-mouse in diluting buffer was added to each well, and the plate was incubated for 1 hour at room temperature. The wells were washed with washing buffer, after which 100 l of peroxidase-conjugated streptavidin in diluting buffer was added to each well. The plate was incubated for 30 minutes at room temperature, after which the wells were washed with washing buffer and water and incubated with 100 l of substrate ( A blocking ELISA (b-ELISA) format was also developed. It was similar to the c-ELISA except that diluted test sera (total volume of 50 l) was added to the viral antigen-coated wells of the microtiter plate and allowed to react for 30 minutes before the monoclonal antibody (50 l/well) was added. The reaction was then allowed to proceed for an additional 90 minutes, after which the microtiter wells were washed and the remaining steps, as outlined above, were followed.
Both competitive and blocking formats for the ELISA were evaluated for sensitivity and specificity. Experimental test sera were produced in cattle by injection of 41B), BTV-17 (63-66B), EHDV-1 (New Jersey), or EHDV-2 (Alberta) by the subcutaneous and intradermal routes of inoculation. Optimal reagent concentrations for the ELISA procedures were determined by crisscross serial-dilution analyses. 5 A 1:50 to 1:100 dilution of the hybridoma supernatant fluid and a 1:10 dilution of experimental test serum gave the most consistent and reproducible results in both ELISA formats. Both EHDV-1 and EHDV-2 antigen preparations were evaluated, and the optimal dilution of viral antigen was determined for each preparation to give an OD value between 1.000 and 1.500 in the absence of inhibition of binding of the monoclonal antibody with preimmune test serum. Composite results for both the c-ELISA and the b-ELISA formats, with either EHDV-1 or EHDV-2 antigen, for detection of antibody to EHDV in the sera of experimentally infected animals are shown in Fig. 2 . The different ELISA formats could differentiate animals infected with the two serotypes of EHDV from those infected with the four serotypes of BTV that currently circulate in the US. All the ELISA formats (except the c-ELISA with EHDV-2 antigen) detected specific antibody to both EHDV-1 and EHDV-2 by 7 DAI, and were able to distinguish animals that had been infected with EHDV from those that had been infected with BTV. From 14 DAI through 49 DAI, all the ELISA formats distinguished sera from EHDV-infected animals from sera from BTV-infected animals, as measured by at least a 2-fold difference in percentage of inhibition. This sensitivity was comparable to the AGID, 6 which showed weak positives at 7 DAI and positives at 14 DAI and thereafter (data not shown). The heterologous inhibition with sera from BTVinfected animals varied with serotype and tended to increase with time postinfection; however, it was always at least 2fold-lower than the homologous inhibition with sera from EHDV-infected animals. Immune precipitation data have also demonstrated increasing cross-reactivity to VP7 of EHDV, with time postinfection, by heterologous BTV sera (data not shown). Others have shown that calves exposed to EHDV also developed antibodies that cross-reacted with BTV antigens in both the group-specific AGID assay and the immunofluorescence assay. 4 Similar to the present study, the rise in heterologous antibody titers in these calves occurred several weeks after and was several orders of magnitude lower than the rise in homologous antibody titers. The heterologous cross-reactivity detected in the current study might reflect direct competition for binding a specific epitope or may have resulted from steric hindrance through binding a proximal epitope. Heterologous inhibition with serum from BTV-infected animals has also been observed in other b-ELISA and c-ELISA formats for EHDV. 14, 16 The monoclonal antibody in the present study did not show any appreciable binding (Ͻ0.200 OD units) when purified BTV was substituted for EHDV as antigen in the ELISA formats (data not shown).
Both EHDV-1 and EHDV-2 were suitable antigens in either the c-ELISA or the b-ELISA format; however, the use of EHDV-1 antigen gave somewhat greater homologous inhibition values than the use of EHDV-2 antigen. However, the spread between homologous and heterologous serum inhibition was approximately equivalent with either virus preparation as antigen. These differences between antigens may reflect the observation that preparations of EHDV-1 are less contaminated with cellular proteins than are preparations of EHDV-2.
The diagnostic utility of the ELISA procedures was evaluated with field-collected cattle serum samples from the National Animal Disease Center, Ames, Iowa, white-tailed deer serum samples from an epizootic hemorrhagic disease of deer outbreak in 1995 in northeastern Wyoming, and buffalo serum samples from Washington state. Results with the b-ELISA are shown in Table 1 . All of the serum samples that were definite positives by the AGID and immune precipitation gave greater than 80% inhibition in the ELISA. One deer sample that gave a weak positive by the AGID and immune precipitation gave 57.8% inhibition in the ELISA. Similar results were obtained with the c-ELISA (data not shown).
The Ibaraki outbreak in Japan 11 illustrates the potential threat of EHDV to domestic cattle. Serological surveys of slaughter animals in the US indicate that infection of cattle with EHDV does occur; however, clinical disease is usually not observed. 8, 12 Because the grazing habitats of cattle often overlap those of wild ruminants, such as deer and bison, potential exists for transmission of EHDV between these species. The ELISA formats developed in this study are amenable to the detection of antibody to EHDV from different species. Sensitive and specific diagnostic procedures are important for monitoring and studying the epizootiology of disease caused by these viruses. Testing with additional field-collected sera from both cattle and deer and comparisons with AGID results will be necessary to establish positive-negative cutoff values and determine the diagnostic sensitivity and specificity of these ELISA procedures.
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